GB0100092D0 - Treatment of degenerative diseases - Google Patents

Treatment of degenerative diseases

Info

Publication number
GB0100092D0
GB0100092D0 GBGB0100092.6A GB0100092A GB0100092D0 GB 0100092 D0 GB0100092 D0 GB 0100092D0 GB 0100092 A GB0100092 A GB 0100092A GB 0100092 D0 GB0100092 D0 GB 0100092D0
Authority
GB
United Kingdom
Prior art keywords
treatment
degenerative diseases
degenerative
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0100092.6A
Other versions
GB2370770A (en
GB2370770B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CONNOLLY SIMON
Original Assignee
CONNOLLY SIMON
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CONNOLLY SIMON filed Critical CONNOLLY SIMON
Priority to GB0100092A priority Critical patent/GB2370770B/en
Publication of GB0100092D0 publication Critical patent/GB0100092D0/en
Publication of GB2370770A publication Critical patent/GB2370770A/en
Application granted granted Critical
Publication of GB2370770B publication Critical patent/GB2370770B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
GB0100092A 2001-01-03 2001-01-03 Uses of Streptococcus Vaccines Expired - Fee Related GB2370770B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0100092A GB2370770B (en) 2001-01-03 2001-01-03 Uses of Streptococcus Vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0100092A GB2370770B (en) 2001-01-03 2001-01-03 Uses of Streptococcus Vaccines

Publications (3)

Publication Number Publication Date
GB0100092D0 true GB0100092D0 (en) 2001-02-14
GB2370770A GB2370770A (en) 2002-07-10
GB2370770B GB2370770B (en) 2005-06-01

Family

ID=9906179

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0100092A Expired - Fee Related GB2370770B (en) 2001-01-03 2001-01-03 Uses of Streptococcus Vaccines

Country Status (1)

Country Link
GB (1) GB2370770B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
CA2804709A1 (en) * 2010-07-26 2012-02-02 Qu Biologics Inc. Immunogenic anti-inflammatory compositions
WO2015164979A1 (en) 2014-05-02 2015-11-05 Qu Biologics Inc. Anti-microbial immunomodulation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3487148A (en) * 1967-04-18 1969-12-30 Us Health Education & Welfare Partially digested m protein vaccine and method of making same
FR2253499B1 (en) * 1973-12-10 1977-11-04 Fabre Sa Pierre
US4521405A (en) * 1982-05-17 1985-06-04 John McMichael Methods and materials for treatment of disease states involving immunological factors
WO1995005454A1 (en) * 1992-02-22 1995-02-23 Cambridge Bacteriophage Technologies Ltd. Engineered bacteriophages and vaccines containing them
US5624904A (en) * 1993-11-17 1997-04-29 Massachusetts Institute Of Technology Method for treating gram positive septicemia
US5846547A (en) * 1996-01-22 1998-12-08 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
CA2243730C (en) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Streptococcus equi vaccine
CA2303478C (en) * 1997-09-12 2008-09-02 James B. Dale Group a streptococcal vaccines
PL203917B1 (en) * 1999-03-19 2009-11-30 Glaxosmithkline Biolog Sa Vaccine
WO2000067784A1 (en) * 1999-05-10 2000-11-16 University Of Maryland, Baltimore Bacteriophage isolated from bacterial genomes and extrachromosomal elements and methods of use thereof

Also Published As

Publication number Publication date
GB2370770A (en) 2002-07-10
GB2370770B (en) 2005-06-01

Similar Documents

Publication Publication Date Title
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
GB2393202B (en) Methods of well treatment
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
AU7434101A (en) Treatment of bone diseases
HUP0400024A3 (en) Combination for treatment of neoplastic diseases
GB0004531D0 (en) The treatment of respiratory diseases
GB0124124D0 (en) Methods of treatment
EP1411985A4 (en) Treatment of parasitic disease
EP1389105A4 (en) Method of treatment
GB0112216D0 (en) Method of treatment
GB0201025D0 (en) The treatment of degenerative diseases
GB0101146D0 (en) Treatment of skin conditions
GB0100092D0 (en) Treatment of degenerative diseases
AU2002242293A1 (en) Treatment of neurological disease
AU1324002A (en) Treatment of demyelinating diseases
AU2002365654A8 (en) Treatment of diseases via the skin
GB0112330D0 (en) Treatment of degenerative lung disease
GB0120253D0 (en) Treatment of neuroinflammatory disease
GB0108892D0 (en) The treatment of respiratory diseases
AU2002327697A1 (en) Compounds for the treatment of pain
AU2002256622A1 (en) Regulation of human dipeptidyl peptidase 8
AU2002249232A1 (en) Use of $g(g)-gt inhibitors for the treatment of degenerative diseases
GB0130191D0 (en) Therapeutic treatment
GB0219811D0 (en) Treatment of excreta

Legal Events

Date Code Title Description
746 Register noted 'licences of right' (sect. 46/1977)

Effective date: 20051107

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20160103